Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
Titel:
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
Auteur:
Viermyr, Hans-Kittil Tonby, Kristian Ponzi, Erica Trouillet-Assant, Sophie Poissy, Julien Arribas, José R. Dyon-Tafani, Virginie Bouscambert-Duchamp, Maude Assoumou, Lambert Halvorsen, Bente Tekin, Nuriye Basdag Diallo, Alpha De Gastines, Lucie Munthe, Ludvig A. Murphy, Sarah Louise Ueland, Thor Michelsen, Annika E. Lund-Johansen, Fridtjof Aukrust, Pål Mootien, Joy Dervieux, Benjamin Zerbib, Yoann Richard, Jean-Christophe Prével, Renaud Malvy, Denis Timsit, Jean-François Peiffer-Smadja, Nathan Roux, Damien Piroth, Lionel Ait-Oufella, Hafid Vieira, Cesar Dalgard, Olav Heggelund, Lars Müller, Karl Erik Møller, Jannicke Horjen Kildal, Anders Benjamin Skogen, Vegard Aballi, Saad Sjøberg Øgaard, Jonas Daniel Dyrhol-Riise, Anne Ma Tveita, Anders Alirezaylavasani, Amin Costagliola, Dominique Yazdanpanah, Yazdan Olsen, Inge Christoffer Dahl, Tuva Børresdatter Kared, Hassen Holten, Aleksander Rygh Trøseid, Marius